Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

Next Previous
Trial Profile

Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Icomidocholic acid (Primary)
  • Indications Cholelithiasis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Galmed Pharmaceuticals

Most Recent Events

  • 02 Oct 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
  • 13 May 2015 According to a Galmed media release, the enrolment pace of the trial has tracked significantly slower than anticipated. Therefore, the company decided to expand the trial into 3 additional centers. However, enrolment has still continued to disappoint. Therefore, the company has filed a request with the principal investigator to cease enrollment in the underperforming center. The company is taking this opportunity to reexamine the study design in order to achieve a better recruitment.
  • 05 Jan 2015 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top